Development of curcumin as an epigenetic agent

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer

• Publication date

  2010-10-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cncr.25414PMID 20597137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

  2010cited by this paper
• Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.

  2010cited by this paper
• Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.

  2009cited by this paper
• Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.

  2009cited by this paper
• DNA hypomethylation in cancer cells.

  2009cited by this paper
• Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

  2009cited by this paper
• Role of HDAC2 in the pathophysiology of COPD.

  2009cited by this paper
• Curcumin-induced histone acetylation in malignant hematologic cells

  2009cited by this paper
• Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.

  2009cited by this paper
• Computational screening of molecular targets in Plasmodium for novel non resistant anti-malarial drugs

  2009cited by this paper
• Many roads to maturity: microRNA biogenesis pathways and their regulation

  2009cited by this paper
• Bryostatin 1 activated PKD1 and β-catenin signaling

  2009cited by this paper
• The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

  2009cited by this paper
• Histone acetyl transferases as emerging drug targets.

  2009cited by this paper
• The role of microRNAs in gastrointestinal cancers

  2009cited by this paper
• Curcumin is a potent DNA hypomethylation agent.

  2009influential reference
• Causes and consequences of microRNA dysregulation in cancer

  2009cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.

  2008influential reference
• Curcumin: a Potential Cancer Chemopreventive Agent through Suppressing NF-κB Signaling

  2008cited by this paper
• Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature.

  2008cited by this paper
• Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.

  2008cited by this paper
• Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

  2008cited by this paper
• Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome.

  2008cited by this paper
• Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2.

  2008cited by this paper
• Curcumin prevents and reverses murine cardiac hypertrophy.

  2008cited by this paper
• Cancer epigenomics: DNA methylomes and histone-modification maps

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• Characterization of novel inhibitors of histone acetyltransferases

  2007cited by this paper
• Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

  2007cited by this paper
• Histone acetyltransferase complexes: one size doesn't fit all

  2007cited by this paper
• Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.

  2007cited by this paper
• Anti-Histone Acetyltransferase Activity from Allspice Extracts Inhibits Androgen Receptor-Dependent Prostate Cancer Cell Growth

  2007cited by this paper
• Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design

  2007cited by this paper
• MicroRNAs in human cancer: from research to therapy

  2007cited by this paper
• MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

  2007cited by this paper
• Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

  2006cited by this paper
• Rapid alteration of microRNA levels by histone deacetylase inhibition.

  2006cited by this paper
• Histone modifications in status epilepticus induced by kainate.

  2006cited by this paper
• Curcumin is an inhibitor of p300 histone acetylatransferase.

  2006cited by this paper
• Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.

  2006cited by this paper
• Epigenetic therapy of cancer: past, present and future

  2006cited by this paper
• Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.

  2006cited by this paper
• Curcumin-induced Histone Hypoacetylation Enhances Caspase-3-dependent Glioma Cell Death and Neurogenesis of Neural Progenitor Cells

  2006cited by this paper
• Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum: Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species

  2006cited by this paper
• Transcriptional regulation of VCAM‐1 expression by tumor necrosis factor‐α in human tracheal smooth muscle cells: Involvement of MAPKs, NF‐κB, p300, and histone acetylation

  2006cited by this paper
• Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

  2005cited by this paper
• Journal of Carcinogenesis BioMed Central Review Estrogen, mitochondria, and growth of cancer and non-cancer cells

  2005cited by this paper
• [DNA methylation and cancer].

  2005cited by this paper
• Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice

  2005cited by this paper
• Identification of hundreds of conserved and nonconserved human microRNAs

  2005cited by this paper
• Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance

  2004cited by this paper
• Phase I Clinical Trial of Oral Curcumin

  2004cited by this paper
• Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription*

  2004cited by this paper
• Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells

  2004cited by this paper
• DNA methylation and cancer.

  2004cited by this paper
• Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells.

  2003cited by this paper
• The diverse functions of histone acetyltransferase complexes.

  2003cited by this paper
• Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

  2001cited by this paper
• Duration of nuclear NF-kappaB action regulated by reversible acetylation.

  2001cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper
• Stability of curcumin in buffer solutions and characterization of its degradation products.

  1997cited by this paper
• Bmc Complementary and Alternative Medicine Dose Escalation of a Curcuminoid Formulation

  year unknowncited by this paper

• Therapeutic Advances of Curcumin and Nanocurcumin in Glioblastoma: Molecular Targets, Bioavailability, and Drug Delivery

  2026cites this paper
• Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC

  2025cites this paper
• Evolutionary conservation and cancer implications of the WNT signaling pathway

  2025cites this paper
• The golden touch: a comprehensive network pharmacology-guided review of synergy between curcumin and PARP inhibitors

  2025cites this paper
• Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer

  2025cites this paper
• Unveiling the influence of polyphenols on histone modifications in human diseases.

  2025cites this paper
• On the health effects of curcumin and its derivatives

  2024cites this paper
• Epigenetic Impact of Curcumin and Thymoquinone on Cancer Therapeutics.

  2024cites this paper
• Garlic‐derived compounds: Epigenetic modulators and their antitumor effects

  2024cites this paper
• Potential of resveratrol as an epigenetic therapy for flavivirus infection

  2023cites this paper
• Methylation of the Vitamin D Receptor Gene in Human Disorders

  2023cites this paper
• Curcumin Combats Against Gastrointestinal Cancer: A Review of Current Knowledge Regarding Epigenetics Mechanisms with a Focus on DNA Methylation.

  2023cites this paper
• The influence of epigenetics and inflammation on cardiometabolic risks.

  2023cites this paper
• Curcumin: An epigenetic regulator and its application in cancer.

  2022cites this paper
• Curcumin Modulates Oxidative Stress, Fibrosis, and Apoptosis in Drug-Resistant Cancer Cell Lines

  2022cites this paper
• Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells.

  2022cites this paper
• Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance.

  2022cites this paper
• Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.

  2021cites this paper
• Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting)

  2021cites this paper
• Curcumin increases crizotinib sensitivity through the inactivation of autophagy via epigenetic modulation of the miR-142-5p/Ulk1 axis in non-small cell lung cancer

  2021cites this paper
• Epigenetic Basis of Polyphenols in Cancer Prevention and Therapy

  2021cites this paper
• Bioactive Dietary Compounds and Epigenetics in Women's Reproductive Cancers

  2021cites this paper
• Use of Curcumine with Tyrosine Kinase Inhibitors in EGFR-mutant Non-Small Cell Lung Cancer. A Phase I prospective Cohort Trial

  2021cites this paper
• Epigenetics/Epigenomics of Triterpenoids in Cancer Prevention and in Health.

  2020cites this paper
• Effects of Somatostatin, Curcumin and Quercetin on the fatty acid profile of breast cancer cell membranes.

  2020cites this paper
• Natural products as LSD1 inhibitors for cancer therapy

  2020cites this paper
• HAT inhibitors in cancer therapy

  2020cites this paper
• Curcumin and Cancer: Can It Supplement Chemotherapies for Cancers?

  2020cites this paper
• Increased p300/CBP expression in acute respiratory distress syndrome is associated with interleukin‐17 and prognosis

  2020cites this paper
• Transforming Curry Extract to Liposomal Curcumin (LipocurcTM)in Parkinson Disease (PD) Therapeutics Landscape: EmergingRole of Epigenetics Signaling and Nanotechnology

  2020cites this paper
• Recent advances in inducing endophytic fungal specialized metabolites using small molecule elicitors including epigenetic modifiers.

  2020cites this paper
• Developing effective combination therapy for pancreatic cancer: an overview.

  2020cites this paper
• Curcumin and Genistein Enhance the Sensitivity of Pancreatic Cancer to Chemotherapy

  2019cites this paper
• Epigenetic Effects of Curcumin in Cancer Prevention

  2019cites this paper
• Epigenetic Aspects of Hepatocellular Carcinoma Chemoprevention

  2019cites this paper
• Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.

  2019cites this paper
• Pharmacokinetics, pharmacodynamics and PKPD modeling of curcumin in regulating antioxidant and epigenetic gene expression in human healthy volunteers

  2019cites this paper
• Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications

  2019cites this paper
• Curcuminoid Analogs Differentially Modulate Nuclear Factor Kappa-Light-Chain-Enhancer, P65 Serine276, Mitogen- and Stress-activated Protein Kinase 1 And MicroRNA 148a Status

  2019cites this paper
• An Assessment of the Increase in Fetal Hemoglobin Gene Expression in the K562 Cell Line Treated by Dendrosomal Nano- curcumin

  2019cites this paper
• Epigenetic Drug Discovery for Cancer

  2019cites this paper
• Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells

  2019cites this paper
• Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects

  2019cites this paper
• Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective

  2019cites this paper
• Histone Acetyltransferases: Targets and Inhibitors

  2019cites this paper
• Dietary and Lifestyle Factors in Epigenetic Regulation of Cancer

  2019cites this paper
• Histone Acetyltransferase Enzymes: From Biological Implications to Most Relevant Inhibitors

  2019cites this paper
• Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer

  2019cites this paper
• Epigenetic drug discovery: systematic assessment of chemical space.

  2019cites this paper
• Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications.

  2018cites this paper
• Epigenetic modulation by small molecule compounds for neurodegenerative disorders

  2018cites this paper
• Vitamin D receptor gene methylation in hepatocellular carcinoma.

  2018cites this paper
• Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets

  2018cites this paper
• Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses

  2018cites this paper
• Chapter 7 Epigenome , Cancer Prevention and Flavonoids and Curcumin

  2018cites this paper
• Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines

  2018cites this paper
• Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test

  2018cites this paper
• Kinase-targeted cancer therapies: progress, challenges and future directions

  2018cites this paper
• Induction of Cryptic and Bioactive Metabolites through Natural Dietary Components in an Endophytic Fungus Colletotrichum gloeosporioides (Penz.) Sacc.

  2017cites this paper
• EBV based cancer prevention and therapy in nasopharyngeal carcinoma

  2017cites this paper
• Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges

  2017cites this paper
• Polyphenol-Related Epigenetic Modifications in Osteoarthritis: Current Therapeutic Perspectives.

  2017cites this paper
• Preclinical Studies and Translational Applications of Intracerebral Hemorrhage

  2017cites this paper
• Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma

  2017cites this paper
• Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis

  2017cites this paper
• Different functions of the histone acetyltransferase HAC1 gene traced in the model species Medicago truncatula, Lotus japonicus and Arabidopsis thaliana

  2017influential citation
• Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.

  2017cites this paper
• Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack

  2017cites this paper
• Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

  2017cites this paper
• Synthesis of Curcuminoids and Evaluation of Their Cytotoxic and Antioxidant Properties

  2017cites this paper
• Comparison of the Effects of Curcumin and RG108 on NGF-Induced PC-12 Adh Cell Differentiation and Neurite Outgrowth

  2017cites this paper
• Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases.

  2017cites this paper
• Cancer and Chemoprevention: An Overview

  2017cites this paper
• An investigation of curcumin derivatives and their effects in prostate cancer

  2017cites this paper
• Anticancer Plants: Clinical Trials and Nanotechnology

  2017cites this paper
• A Review of the Effects of Curcumin on Histone Acetyltransferase Activity in the Prevention of Cardiac Hypertrophy

  2017cites this paper
• Modulation of Wnt/β-Catenin Signaling by Chemoprevention

  2017cites this paper
• Signaling Pathways of Anticancer Plants: Action and Reaction

  2017cites this paper
• Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity.

  2017cites this paper
• Epigenetic targets in cancer and aging: dietary and therapeutic interventions

  2016cites this paper
• KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.

  2016cites this paper
• Molecular Targets and Strategies in Cancer Prevention

  2016cites this paper
• Curcumin: The epigenetic therapy

  2016cites this paper
• Targeting MicroRNAs: Molecular Basis of Cancer Prevention

  2016cites this paper
• Epigenetic Changes and Potential Targets in Pancreatic Cancer

  2016cites this paper
• Nutritional and Lifestyle Impact on Epigenetics and Cancer

  2016cites this paper
• The model beetle Tribolium castaneum can be used as an early warning system for transgenerational epigenetic side effects caused by pharmaceuticals.

  2016cites this paper
• Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis

  2016cites this paper
• The role of natural polyphenols in cell signaling and cytoprotection against cancer development.

  2016cites this paper
• The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer

  2016cites this paper
• Nutraceuticals as Chemopreventive and Therapeutic agents in Gut AssociatedPathogenesis

  2016cites this paper
• Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2

  2016cites this paper
• Cancer Chemoprotection Through Nutrient-mediated Histone Modifications

  2016cites this paper
• Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms

  2016cites this paper
• Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21

  2016cites this paper
• Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

  2016cites this paper
• Natural compounds: Role in reversal of epigenetic changes

  2015cites this paper
• Capsaicin-induced genotoxic stress does not promote apoptosis in A549 human lung and DU145 prostate cancer cells.

  2015cites this paper
• GRP78 mediates the therapeutic efficacy of curcumin on colon cancer

  2015cites this paper
• Curcumin induces oxidation-dependent cell cycle arrest mediated by SIRT7 inhibition of rDNA transcription in human aortic smooth muscle cells.

  2015cites this paper